BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26767014)

  • 21. Reirradiation of thoracic cancers with intensity modulated proton therapy.
    Ho JC; Nguyen QN; Li H; Allen PK; Zhang X; Liao Z; Zhu XR; Gomez D; Lin SH; Gillin M; Komaki R; Hahn S; Chang JY
    Pract Radiat Oncol; 2018; 8(1):58-65. PubMed ID: 28867546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reirradiation of locally recurrent nasopharyngeal carcinoma.
    Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
    Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
    Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
    J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thoracic reirradiation for lung cancer: a literature review and practical guide.
    Drodge CS; Ghosh S; Fairchild A
    Ann Palliat Med; 2014 Apr; 3(2):75-91. PubMed ID: 25841506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose, conventionally fractionated thoracic reirradiation for lung tumors.
    Griffioen GH; Dahele M; de Haan PF; van de Ven PM; Slotman BJ; Senan S
    Lung Cancer; 2014 Mar; 83(3):356-62. PubMed ID: 24433824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients.
    Jereczek-Fossa BA; Kowalczyk A; D'Onofrio A; Catalano G; Garibaldi C; Boboc G; Vitolo V; Leonardi MC; Cambria R; Orecchia R
    Strahlenther Onkol; 2008 Jan; 184(1):36-40. PubMed ID: 18188521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsed Reduced Dose Rate for Reirradiation of Recurrent Breast Cancer.
    Burr AR; Robins HI; Bayliss RA; Howard SP
    Pract Radiat Oncol; 2020; 10(2):e61-e70. PubMed ID: 31526900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
    Koong AJ; Toesca DAS; von Eyben R; Pollom EL; Chang DT
    Adv Radiat Oncol; 2017; 2(1):27-36. PubMed ID: 28740913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy.
    Milker-Zabel S; Zabel A; Thilmann C; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):162-7. PubMed ID: 12504049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
    Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
    J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases.
    Xiang-E W; Shu-mo C; Ya-qin D; Ke W
    Gynecol Oncol; 1998 May; 69(2):125-9. PubMed ID: 9600819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
    Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
    Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
    Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
    J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
    Rusthoven KE; Feigenberg SJ; Raben D; Kane M; Song JI; Nicolaou N; Mehra R; Burtness B; Ridge J; Swing R; Lango M; Cohen R; Jimeno A; Chen C
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1020-5. PubMed ID: 20231078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic Radiation Pneumonitis After Accelerated Partial Breast Irradiation Using Three-dimensional Conformal Radiotherapy.
    Shikama N; Kumazaki YU; Miyazawa K; Miyaura K; Kato S; Nakamura N; Kawamori J; Shimizuguchi T; Saito N; Saeki T
    Anticancer Res; 2016 May; 36(5):2475-9. PubMed ID: 27127160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and palliative efficacy of single-dose 8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy.
    Topkan E; Yildirim BA; Guler OC; Parlak C; Pehlivan B; Selek U
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):774-80. PubMed ID: 25752391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy].
    Wang JB; Jiang W; Ji Z; Cao JZ; Liu LP; Men Y; Xu C; Wang XZ; Hui ZG; Liang J; Lyu JM; Zhou ZM; Xiao ZF; Feng QF; Chen DF; Zhang HX; Yin WB; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):607-14. PubMed ID: 27531481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.